{
    "annotations": [
        {
            "identifier": "T1",
            "position": [
                "369",
                "375"
            ],
            "subtype": "Drug",
            "type": "T",
            "value": "Acesan"
        },
        {
            "identifier": "T2",
            "position": [
                "423",
                "431"
            ],
            "subtype": "Drug",
            "type": "T",
            "value": "Spironol"
        },
        {
            "identifier": "T3",
            "position": [
                "482",
                "491"
            ],
            "subtype": "Drug",
            "type": "T",
            "value": "Enalapril"
        },
        {
            "identifier": "T4",
            "position": [
                "375",
                "420"
            ],
            "subtype": "Drug_dose",
            "type": "T",
            "value": "1x dziennie 15mg doustnie (1/2 tabletki 30mg)"
        },
        {
            "identifier": "T5",
            "position": [
                "432",
                "479"
            ],
            "subtype": "Drug_dose",
            "type": "T",
            "value": "1x dziennie 12,5mg doustnie (1/2 tabletki 25mg)"
        },
        {
            "identifier": "T6",
            "position": [
                "492",
                "518"
            ],
            "subtype": "Drug_dose",
            "type": "T",
            "value": "1x dziennie 0,8mg doustnie"
        },
        {
            "identifier": "T7",
            "position": [
                "638",
                "646"
            ],
            "subtype": "Drug",
            "type": "T",
            "value": "Spironol"
        },
        {
            "identifier": "T8",
            "position": [
                "648",
                "654"
            ],
            "subtype": "Drug",
            "type": "T",
            "value": "Acesan"
        },
        {
            "identifier": "T9",
            "position": [
                "656",
                "665"
            ],
            "subtype": "Drug",
            "type": "T",
            "value": "Enalapril"
        },
        {
            "identifier": "T10",
            "position": [
                "667",
                "676"
            ],
            "subtype": "Drug",
            "type": "T",
            "value": "Cefazolin"
        },
        {
            "identifier": "T11",
            "position": [
                "796",
                "809"
            ],
            "subtype": "Drug",
            "type": "T",
            "value": "Spironolakton"
        },
        {
            "identifier": "T12",
            "position": [
                "811",
                "820"
            ],
            "subtype": "Drug",
            "type": "T",
            "value": "enalapryl"
        },
        {
            "identifier": "T13",
            "position": [
                "822",
                "830"
            ],
            "subtype": "Drug",
            "type": "T",
            "value": "ANA 1:1,"
        },
        {
            "identifier": "T14",
            "position": [
                "831",
                "840"
            ],
            "subtype": "Drug",
            "type": "T",
            "value": "Cefazolin"
        },
        {
            "identifier": "T15",
            "position": [
                "1075",
                "1090"
            ],
            "subtype": "Symptom",
            "type": "T",
            "value": "Stan do\u015b\u0107 dobry"
        },
        {
            "identifier": "T16",
            "position": [
                "979",
                "998"
            ],
            "subtype": "Condition",
            "type": "T",
            "value": "wrodzon\u0105 wad\u0105 serca"
        },
        {
            "identifier": "T17",
            "position": [
                "1230",
                "1248"
            ],
            "subtype": "Condition",
            "type": "T",
            "value": "z\u0142o\u017cona wad\u0105 serca"
        },
        {
            "identifier": "T18",
            "position": [
                "1254",
                "1271"
            ],
            "subtype": "Treatment",
            "type": "T",
            "value": "operacji Norwooda"
        },
        {
            "identifier": "T19",
            "position": [
                "1287",
                "1324"
            ],
            "subtype": "Treatment",
            "type": "T",
            "value": "kolejnego etapu leczenia operacyjnego"
        },
        {
            "identifier": "T20",
            "position": [
                "1346",
                "1352"
            ],
            "subtype": "Drug",
            "type": "T",
            "value": "Acesan"
        },
        {
            "identifier": "T21",
            "position": [
                "1355",
                "1364"
            ],
            "subtype": "Drug",
            "type": "T",
            "value": "Enarapril"
        },
        {
            "identifier": "T22",
            "position": [
                "1367",
                "1375"
            ],
            "subtype": "Drug",
            "type": "T",
            "value": "Spironol"
        },
        {
            "identifier": "T23",
            "position": [
                "1389",
                "1434"
            ],
            "subtype": "Treatment",
            "type": "T",
            "value": "pod opiek\u0105 genetyka, neurologa, rehabilitanta"
        },
        {},
        {
            "icd": "ICD10:Q20",
            "identifier": "N1",
            "referenced": "T16",
            "subtype": "Reference",
            "type": "N",
            "value": "Wrodzone wady rozwojowe jam i po\u00c5\u0082\u00c4\u0085cze\u00c5\u0084 sercowych"
        },
        {
            "icd": "ICD10:Z98.8",
            "identifier": "N2",
            "referenced": "T18",
            "subtype": "Reference",
            "type": "N",
            "value": "Inne okre\u00c5\u009blone stany po zabiegach chirurgicznych"
        },
        {
            "arg1": "T1",
            "arg2": "T4",
            "identifier": "R1",
            "subtype": "Drg",
            "type": "R"
        },
        {
            "arg1": "T2",
            "arg2": "T5",
            "identifier": "R5",
            "subtype": "Drg",
            "type": "R"
        },
        {
            "arg1": "T3",
            "arg2": "T6",
            "identifier": "R9",
            "subtype": "Drg",
            "type": "R"
        }
    ],
    "originalText": "------------------------------------------------\nWiek: 2 lat\n------------------------------------------------\n------------------------------------------------\nP\u0142e\u0107: \u017ce\u0144ska\n------------------------------------------------\n------------------------------------------------\nZalecenia\n------------------------------------------------\nDalsze regularnie przyjmowanie lek\u00f3w:\n- Acesan1x dziennie 15mg doustnie (1/2 tabletki 30mg)\n- Spironol 1x dziennie 12,5mg doustnie (1/2 tabletki 25mg)\n- Enalapril 1x dziennie 0,8mg doustnie\n------------------------------------------------\nZastosowane leczenie\n------------------------------------------------\nSpironol, Acesan, Enalapril, Cefazolin\n------------------------------------------------\nZastosowane leczenie\n------------------------------------------------\nSpironolakton, enalapryl, ANA 1:1, Cefazolin\n------------------------------------------------\nBadanie podmiotowe/Wywiad\n------------------------------------------------\nDziewczynka z wrodzon\u0105 wad\u0105 serca przyj\u0119ta do Kliniki do poszerzonych bada\u0144 i ustalenia dalszego post\u0119powania Stan do\u015b\u0107 dobry\n------------------------------------------------\nBadanie podmiotowe/Wywiad\n------------------------------------------------\ndziewczynka ze z\u0142o\u017cona wad\u0105 serca , po operacji Norwooda, skierowana do kolejnego etapu leczenia operacyjnego , na sta\u0142e otrzymuje Acesan , Enarapril , Spironol, jest  tak\u017ce pod opiek\u0105 genetyka, neurologa, rehabilitanta, wywiad alergiczny ujemny\n------------------------------------------------\nWyniki bada\u0144\n------------------------------------------------\nMorfologia\n    WBC:8.25[10\\\\^3/ul]\n    RBC:5.37[10\\\\^6/ul]\n    HGB:15.0[g/dl]\n    HCT:44.6[%]\n    MCV:83.1[fl]\n    MCH:27.9[pg]\n    MCHC:33.6[g/dl]\n    PLT:215.0[10\\\\^3/ul]\n    RDW-SD:39.8[fl]\n    RDW-CV:13.2[%]\n    PDW:11.6[fl]\n    MPV:10.2[fl]\n    P-LCR:26.0[%]\n    PCT:0.2[%]\n    NEUTR#:2.83[10\\\\^3/ul]\n    NEUTR%:34.3[%]\n    LYMPH#:3.91[10\\\\^3/ul]\n    LYMPH%:47.4[%]\n    MONO#:0.82[10\\\\^3/ul]\n    MONO%:9.90[%]\n    EO#:0.65[10\\\\^3/ul]\n    EO%:7.90[%]\n    BASO#:0.04[10\\\\^3/ul]\n    BASO%:0.50[%]\n    NRBC %:0.00[%]\n    NRBC#:0.00[10\\\\^3/ul]\nMorfologia\n    WBC:5.79[10\\\\^3/ul]\n    RBC:5.11[10\\\\^6/ul]\n    HGB:14.3[g/dl]\n    HCT:42.4[%]\n    MCV:83.0[fl]\n    MCH:28.0[pg]\n    MCHC:33.7[g/dl]\n    PLT:293.0[10\\\\^3/ul]\n    RDW-SD:39.7[fl]\n    RDW-CV:13.1[%]\n    PDW:11.1[fl]\n    MPV:10.1[fl]\n    P-LCR:25.4[%]\n    PCT:0.3[%]\n    NEUTR#:3.27[10\\\\^3/ul]\n    NEUTR%:56.4[%]\n    LYMPH#:1.58[10\\\\^3/ul]\n    LYMPH%:27.3[%]\n    MONO#:0.74[10\\\\^3/ul]\n    MONO%:12.80[%]\n    EO#:0.16[10\\\\^3/ul]\n    EO%:2.80[%]\n    BASO#:0.04[10\\\\^3/ul]\n    BASO%:0.70[%]\n    NRBC %:0.00[%]\n    NRBC#:0.00[10\\\\^3/ul]\nMorfologia\n    WBC:11.43[10\\\\^3/ul]\n    RBC:5.33[10\\\\^6/ul]\n    HGB:15.7[g/dl]\n    HCT:43.6[%]\n    MCV:81.8[fl]\n    MCH:29.5[pg]\n    MCHC:36.0[g/dl]\n    PLT:312.0[10\\\\^3/ul]\n    RDW-SD:41.1[fl]\n    RDW-CV:14.0[%]\n    PDW:11.3[fl]\n    MPV:9.8[fl]\n    P-LCR:23.3[%]\n    PCT:0.3[%]\n    NEUTR#:6.73[10\\\\^3/ul]\n    NEUTR%:58.9[%]\n    LYMPH#:2.93[10\\\\^3/ul]\n    LYMPH%:25.6[%]\n    MONO#:1.22[10\\\\^3/ul]\n    MONO%:10.70[%]\n    EO#:0.51[10\\\\^3/ul]\n    EO%:4.50[%]\n    BASO#:0.04[10\\\\^3/ul]\n    BASO%:0.30[%]\n    NRBC %:0.00[%]\n    NRBC#:0.00[10\\\\^3/ul]\nMorfologia\n    WBC:10.31[10\\\\^3/ul]\n    RBC:5.26[10\\\\^6/ul]\n    HGB:15.1[g/dl]\n    HCT:43.0[%]\n    MCV:81.7[fl]\n    MCH:28.7[pg]\n    MCHC:35.1[g/dl]\n    PLT:296.0[10\\\\^3/ul]\n    RDW-SD:41.0[fl]\n    RDW-CV:13.9[%]\n    PDW:11.3[fl]\n    MPV:9.8[fl]\n    P-LCR:23.1[%]\n    PCT:0.3[%]\n    NEUTR#:6.24[10\\\\^3/ul]\n    NEUTR%:60.5[%]\n    LYMPH#:2.40[10\\\\^3/ul]\n    LYMPH%:23.3[%]\n    MONO#:0.99[10\\\\^3/ul]\n    MONO%:9.60[%]\n    EO#:0.63[10\\\\^3/ul]\n    EO%:6.10[%]\n    BASO#:0.05[10\\\\^3/ul]\n    BASO%:0.50[%]\n    NRBC %:0.00[%]\n    NRBC#:0.00[10\\\\^3/ul]\nABL Parametry krytyczne\n    pH:7.388\n    pCO2:38.8[mmHg]\n    BE:-1.40[mmol/L]\n    HCO3:22.8[mmol/L]\n    pO2:33.8[mmHg]\n    O2Sat:59.6[%]\n    Na - ABL:140[mmol/L]\n    K - ABL:5.2[mmol/L]\n    Cl - ABL:109[mmol/L]\n    Ca zj ABL:1.30[mmol/L]\n    Ht - ABL:53.1[%]\n    Hb ABL:17.4[g/dl]\n    FO2Hb:58.8[%]\n    FCOHb:0.8[%]\n    FMetHb:0.6[%]\n    FHbF - ABL:0.00[%]\n    GLU-ABL:50[mg/dl]\n    mleczany:26[mg/dl]\n    COMMENT_HL7:\nABL Parametry krytyczne\n    pH:7.405\n    pCO2:39.0[mmHg]\n    BE:-0.10[mmol/L]\n    HCO3:23.9[mmol/L]\n    pO2:37.7[mmHg]\n    O2Sat:60.4[%]\n    Na - ABL:138[mmol/L]\n    K - ABL:4.6[mmol/L]\n    Cl - ABL:106[mmol/L]\n    Ca zj ABL:1.24[mmol/L]\n    Ht - ABL:47.1[%]\n    Hb ABL:15.4[g/dl]\n    FO2Hb:59.4[%]\n    FCOHb:0.9[%]\n    FMetHb:0.8[%]\n    FHbF - ABL:0.00[%]\n    GLU-ABL:87[mg/dl]\n    mleczany:25[mg/dl]\n    COMMENT_HL7:\nABL Parametry krytyczne\n    pH:7.381\n    pCO2:40.0[mmHg]\n    BE:-1.20[mmol/L]\n    HCO3:23.2[mmol/L]\n    pO2:33.5[mmHg]\n    O2Sat:53.5[%]\n    Na - ABL:138[mmol/L]\n    K - ABL:4.3[mmol/L]\n    Cl - ABL:107[mmol/L]\n    Ca zj ABL:1.24[mmol/L]\n    Ht - ABL:49.7[%]\n    Hb ABL:16.2[g/dl]\n    FO2Hb:52.9[%]\n    FCOHb:0.7[%]\n    FMetHb:0.5[%]\n    FHbF - ABL:0.00[%]\n    GLU-ABL:109[mg/dl]\n    mleczany:22[mg/dl]\n    COMMENT_HL7:\nBadanie og\u00f3lne moczu\n    Barwa:s\u0142omkowa\n    Przej:zupe\u0142na\n    SG:1.005\n    pH:7.0\n    LEU:nieobecne[ul]\n    NIT:nieobecne[ul]\n    mKET:nieobecne[mg/dl]\n    mURO:niewzmo\u017cony\n    BIL:nieobecna\n    ERY:nieobecne[ul]\n    GLU-mocz:nieobecna[mg/dl]\n    UPROT:nieobecne[mg/dl]\nImmununochemia -Immulite: COMMENT_HL7:\nImmununochemia -Immulite: COMMENT_HL7:\nProkalcytonina (PCT): PROKAL:0.04[ng/ml]\nD-dimery t. ilo\u015bciowy: D-dimer:526.0[ng/ml]\nD-dimery t. ilo\u015bciowy: D-dimer:445.0[ng/ml]\nD-dimery t. ilo\u015bciowy: D-dimer:455.0[ng/ml]\nPLT -  z koagulogramu: PLT-KOAG:259.0[10\\\\^3/ul]\nPLT -  z koagulogramu: PLT-KOAG:182.0[10\\\\^3/ul]\nFibrynogen (F): FIB:3.34[g/L]\nFibrynogen (F): FIB:4.16[g/L]\nFibrynogen (F): FIB:3.68[g/L]\nAntytrombina III (ATIII): ATIII:108.0[%]\nAntytrombina III (ATIII): ATIII:100.0[%]\nAntytrombina III (ATIII): ATIII:100.0[%]\nCzas kaolinowo-kefalinowy ( APTT- SP): APTT:31.5[s]\nCzas kaolinowo-kefalinowy ( APTT- SP): APTT:30.6[s]\nCzas kaolinowo-kefalinowy ( APTT- SP): APTT:30.6[s]\nINR: INR:1.2\nINR: INR:1.2\nINR: INR:1.2\nCzas protrombinowy (PT): PT:13.1[s]\nCzas protrombinowy (PT): PT:13.3[s]\nCzas protrombinowy (PT): PT:12.9[s]\nCzas trombinowy (TT): TT:13.7[s]\nCzas trombinowy (TT): TT:13.9[s]\nCzas trombinowy (TT): TT:13.1[s]\nAdenowirusy: ADENO-KA\u0141:ujemny\nMagnez: Mg:0.88[mmol/L]\nTriglicerydy: TRIG:167.00[mg/dl]\nTriglicerydy: TRIG:153.00[mg/dl]\nCholesterol: CHOL:132.00[mg/dl]\nCholesterol: CHOL:125.00[mg/dl]\nBilirubina ca\u0142kowita TBIL: TBIL:0.50[mg/dl]\nBilirubina ca\u0142kowita TBIL: TBIL:0.60[mg/dl]\nBia\u0142ko CRP\n    CRP:\n    0.50[mg/dl]\nBia\u0142ko CRP: CRP:1.21[mg/dl]\nBia\u0142ko CRP\n    CRP:\n    0.50[mg/dl]\nBia\u0142ko CRP: CRP:0.60[mg/dl]\nBia\u0142ko CRP: CRP:0.64[mg/dl]\nWska\u017anik PT: PT%:84[%]\nWska\u017anik PT: PT%:83[%]\nWska\u017anik PT: PT%:85[%]\nBia\u0142ko ca\u0142kowite: TP:7.20[g/dl]\nKreatynina: CREA:0.40[mg/dl]\nKreatynina: CREA:0.50[mg/dl]\nKreatynina: CREA:0.40[mg/dl]\nKreatynina: CREA:0.40[mg/dl]\nKreatynina: CREA:0.40[mg/dl]\nMocznik: UREA:39.00[mg/dl]\nMocznik: UREA:47.00[mg/dl]\nMocznik: UREA:34.00[mg/dl]\nMocznik: UREA:34.00[mg/dl]\nCholesterol LDL (met.bezpo\u015brednia): LDL:85.00[mg/dl]\nCholesterol HDL: HDL:36.00[mg/dl]\nASPAT: AST:41.00[IU/L]\nASPAT: AST:47.00[IU/L]\nASPAT: AST:41.00[IU/L]\nASPAT: AST:44.00[IU/L]\nALAT: ALT:41.00[IU/L]\nALAT: ALT:46.00[IU/L]\nALAT: ALT:31.00[IU/L]\nALAT: ALT:41.00[IU/L]\nRotawirusy: ROTA-KA\u0141:ujemny\nPLT z morfologii: PLT:215.0[10\\\\^3/ul]\nNT- proBNP: NTpBNP:614.00[pg/ml]\nNT- proBNP: NTpBNP:746.00[pg/ml]\nGlukoza w surowicy: GLU-sur:69[mg/dl]\nGlukoza w surowicy: GLU-sur:91[mg/dl]\nPosiew - Ka\u0142: POSIEW:\neGFR zmod. wg Schwartza wsp. 0.413: eGFRzmod:80.5[ml/min/1,73m2]\neGFR zmod. wg Schwartza wsp. 0.413: eGFRzmod:64.4[ml/min/1,73m2]\neGFR zmod. wg Schwartza wsp. 0.413: eGFRzmod:80.5[ml/min/1,73m2]\neGFR zmod. wg Schwartza wsp. 0.413: eGFRzmod:82.6[ml/min/1,73m2]\neGFR zmod. wg Schwartza wsp. 0.413: eGFRzmod:82.6[ml/min/1,73m2]\nWzrost pacjenta: WzrostPac:78[cm]\nWzrost pacjenta: WzrostPac:78[cm]\nWzrost pacjenta: WzrostPac:78[cm]\nWzrost pacjenta: WzrostPac:80[cm]\nWzrost pacjenta: WzrostPac:80[cm]\neGFR (1-18r\u017c K) stand.wg.Schwartza  wsp. 0.550: eGFR 1-18K:107.3[ml/min/1,73m2]\neGFR (1-18r\u017c K) stand.wg.Schwartza  wsp. 0.550: eGFR 1-18K:85.8[ml/min/1,73m2]\neGFR (1-18r\u017c K) stand.wg.Schwartza  wsp. 0.550: eGFR 1-18K:107.3[ml/min/1,73m2]\neGFR (1-18r\u017c K) stand.wg.Schwartza  wsp. 0.550: eGFR 1-18K:110.0[ml/min/1,73m2]\neGFR (1-18r\u017c K) stand.wg.Schwartza  wsp. 0.550: eGFR 1-18K:110.0[ml/min/1,73m2]\nNorowirusy w kale\n    Norowir-G1:nie wykryto\n    Norowir-G2:nie wykryto\nImmunochemia - parametry krytyczne: COMMENT_HL7:\nBadanie osadu z moczu odwirowanego\n    wkrwbia\u0142e:pojedyncze w prep.[ul]\n    wnab\u0142onekp:poj. w preparacie\n    wbakter:poj. w pw\n    w\u015bluz:poj. pasma\nPr\u00f3ba zgodno\u015bci (kontrola grupy krwi biorcy)\n    NR-KS:K18/000154\n    DONACJA:Z511518001304\nPr\u00f3ba zgodno\u015bci (kontrola grupy krwi biorcy)\n    NR-KS:K18/000183\n    DONACJA:Z510018000808\nGrupa krwi + p/c odporno\u015bciowe (powy\u017cej 4. m-ca \u017cycia: NR-KS:G18/001046\n------------------------------------------------\nICD10\n------------------------------------------------\nQ25.2\nQ23.0\nQ99.8\nZ98.8\nQ21.0\n------------------------------------------------\n------------------------------------------------\nICD9\n------------------------------------------------\n89.522\n37.21\n88.721\n89.00\n89.602\nG21\nG25\n------------------------------------------------"
}